Policy Manual sample

MDT Home Health Care Agency, Inc. 219 ♦ Selection and procurement ♦ Storage ♦ Ordering and transcribing ♦ Preparing and dispensing ♦ Administration ♦ Monitoring the effects and side effects on patients  Over time, data is collected on all of the above processes. • To adequately monitor and evaluate the medication management system in place within the organization the Performance Improvement Director/Risk Manager collects data on the following:  Processes and outcomes  Medication errors (real and potential)  Adverse drug reactions  High-risk, high-volume and problem-prone processes  Patients needs, expectations and department specific patient satisfaction questionnaires and/or surveys  Infection control activities  Patient safety reports  Current literature for new technologies and best practices  Risk management issues and findings • Performance Measures: • Administration of medication is of high-risk and therapeutic benefit to the patient. Medication management processes are measured on an ongoing basis. The following are performance measures or categories of measures for which data is collected, aggregated, reviewed and analyzed in an effort to identify risk points and areas to improve patient safety. The list is not exhaustive and may be revised in accordance with data collected, which may indicate the benefit of inclusion or exclusion of a performance measure from the monitoring and evaluation cycle. Measures include, but may not be limited to: